Malignant gliomas in adults

被引:3358
作者
Wen, Patrick Y.
Kesari, Santosh
机构
[1] Brigham & Womens Hosp, Div Neurooncol, Dept Neurol, Boston, MA 02115 USA
[2] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02115 USA
关键词
D O I
10.1056/NEJMra0708126
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Malignant gliomas, the most common type of primary brain tumor in adults, are associated with disproportionate cancer-related morbidity and mortality. Recently, there have been important advances in our understanding of the molecular pathogenesis of malignant gliomas and progress in treating them. This review summarizes the diagnosis and management of these tumors in adults, highlighting new advances. Copyright © 2008 Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:492 / 507
页数:16
相关论文
共 113 条
[1]  
Afra D, 2002, LANCET, V359, P1011
[2]   Glial progenitors in adult white matter are driven to form malignant gliomas by platelet-derived growth factor-expressing retroviruses [J].
Assanah, Marcela ;
Lochhead, Richard ;
Ogden, Alfred ;
Bruce, Jeffrey ;
Goldman, James ;
Canoll, Peter .
JOURNAL OF NEUROSCIENCE, 2006, 26 (25) :6781-6790
[3]   Advances in brain tumor surgery [J].
Asthagiri, Ashok R. ;
Pouratian, Nader ;
Sherman, Jonathan ;
Ahmed, Galal ;
Shaffrey, Mark E. .
NEUROLOGIC CLINICS, 2007, 25 (04) :975-+
[4]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[5]   Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor [J].
Bao, Shideng ;
Wu, Qiulian ;
Sathornsumetee, Sith ;
Hao, Yueling ;
Li, Zhizhong ;
Hjelmeland, Anita B. ;
Shi, Oing ;
McLendon, Roger E. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
CANCER RESEARCH, 2006, 66 (16) :7843-7848
[6]   AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients [J].
Batchelor, Tracy T. ;
Sorensen, A. Gregory ;
di Tomaso, Emmanuelle ;
Zhang, Wei-Ting ;
Duda, Dan G. ;
Cohen, Kenneth S. ;
Kozak, Kevin R. ;
Cahill, Daniel P. ;
Chen, Poe-Jou ;
Zhu, Mingwang ;
Ancukiewicz, Marek ;
Mrugala, Maciej M. ;
Plotkin, Scott ;
Drappatz, Jan ;
Louis, David N. ;
Ivy, Percy ;
Scadden, David T. ;
Benner, Thomas ;
Loeffler, Jay S. ;
Wen, Patrick Y. ;
Jain, Rakesh K. .
CANCER CELL, 2007, 11 (01) :83-95
[7]   CD133+ and CD133- glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles [J].
Beier, Dagmar ;
Hau, Peter ;
Proescholdt, Martin ;
Lohmeier, Annette ;
Wischhusen, Joerg ;
Oefner, Peter J. ;
Aigner, Ludwig ;
Brawanski, Alexander ;
Bogdahn, Ulrich ;
Beier, Christoph P. .
CANCER RESEARCH, 2007, 67 (09) :4010-4015
[8]   Clinical features, mechanisms, and management of pseudoprogression in malignant gliomas [J].
Brandsma, Dieto ;
Stalpers, Lukas ;
Taal, Walter ;
Sminia, Peter ;
van den Bent, Martinj .
LANCET ONCOLOGY, 2008, 9 (05) :453-461
[9]   PLACEBO-CONTROLLED TRIAL OF SAFETY AND EFFICACY OF INTRAOPERATIVE CONTROLLED DELIVERY BY BIODEGRADABLE POLYMERS OF CHEMOTHERAPY FOR RECURRENT GLIOMAS [J].
BREM, H ;
PIANTADOSI, S ;
BURGER, PC ;
WALKER, M ;
SELKER, R ;
VICK, NA ;
BLACK, K ;
SISTI, M ;
BREM, S ;
MOHR, G ;
MULLER, P ;
MORAWETZ, R ;
SCHOLD, SC .
LANCET, 1995, 345 (8956) :1008-1012
[10]  
Brem Steven S, 2008, J Natl Compr Canc Netw, V6, P456